• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治疗药物与滥用药物相互作用的药物信息资源评估。

Evaluation of drug information resources for interactions between therapeutic drugs and drugs of abuse.

出版信息

J Med Libr Assoc. 2020 Oct 1;108(4):584-590. doi: 10.5195/jmla.2020.969.

DOI:10.5195/jmla.2020.969
PMID:33013215
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7524612/
Abstract

OBJECTIVE

The study evaluated point-of-care resources for scope, completeness, and consistency of information describing interactions between therapeutic drugs and drugs of abuse (DoA).

METHODS

A cross-sectional evaluation study was conducted focusing on seven resources: Clinical Pharmacology, Facts & Comparisons eAnswers, Lexicomp Online, Micromedex, and A sample of clinically relevant interactions was developed through review of tertiary literature and resources, and input was solicited from subject matter experts. Entries from each resource for each interaction were evaluated for scope (i.e., whether there was an entry for the interaction); completeness (i.e., whether there was information addressing mechanism; clinical effects, severity, course of action, and level of certainty, described as a median rating on a 5-point scale); and consistency (i.e., whether the information in the resource was similar to the majority) among resources with an entry.

RESULTS

Following review by subject matter experts, the final sample contained 159 interactions. Scope scores ranged from 0.6% () to 43.4% (Lexicomp Online). Completeness scores ranged from 2 (interquartile range [IQR] 0 to 3, ) to 5 (IQR 5 to 5, Micromedex, Facts & Comparisons eAnswers). Consistency scores ranged from 30.8% () to 87.1% (Clinical Pharmacology) for severity and from 15.4% (Facts & Comparisons eAnswers) to 71.4% () for course of action.

CONCLUSIONS

Although coverage of drug-DoA interactions was low and content was often inconsistent among resources, the provided information was generally complete.

摘要

目的

本研究评估了即时资源在描述治疗药物与药物滥用(DoA)之间相互作用时的范围、完整性和一致性。

方法

本研究采用横断面评估方法,重点关注七种资源:临床药理学、事实与比较电子答案、Lexicomp Online、Micromedex、和。通过对三级文献和资源的回顾,以及向主题专家征求意见,开发了一组与临床相关的相互作用样本。对每种资源中每种相互作用的条目进行评估,以确定范围(即是否有相互作用的条目);完整性(即是否有信息涉及机制;临床效果、严重程度、行动过程和确定性,并以 5 分制的中位数评分来描述);以及在有条目记录的资源之间的一致性(即资源中的信息是否与多数资源相似)。

结果

经过主题专家审查,最终样本包含 159 种相互作用。范围评分范围从 0.6%(Lexicomp Online)到 43.4%(Lexicomp Online)。完整性评分范围从 2(四分位距 [IQR] 0 到 3,)到 5(Micromedex、事实与比较电子答案)。一致性评分范围从严重程度的 30.8%(Clinical Pharmacology)到 87.1%(Clinical Pharmacology),从行动过程的 15.4%(事实与比较电子答案)到 71.4%()。

结论

尽管药物与药物滥用相互作用的覆盖范围较低,且资源之间的内容往往不一致,但提供的信息通常较为完整。

相似文献

1
Evaluation of drug information resources for interactions between therapeutic drugs and drugs of abuse.治疗药物与滥用药物相互作用的药物信息资源评估。
J Med Libr Assoc. 2020 Oct 1;108(4):584-590. doi: 10.5195/jmla.2020.969.
2
Evaluation of drug information resources for drug-ethanol and drug-tobacco interactions.药物-乙醇和药物-烟草相互作用的药物信息资源评估
J Med Libr Assoc. 2019 Jan;107(1):62-71. doi: 10.5195/jmla.2019.549. Epub 2019 Jan 1.
3
Evaluation of resources for analyzing drug interactions.分析药物相互作用的资源评估。
J Med Libr Assoc. 2016 Oct;104(4):290-295. doi: 10.3163/1536-5050.104.4.007.
4
Off-label use information in electronic drug information resources.电子药物信息资源中的标签外使用信息。
J Med Libr Assoc. 2022 Oct 1;110(4):471-477. doi: 10.5195/jmla.2022.1419.
5
Assessing Consistency of Drug-Drug Interaction-Related Information Across Various Drug Information Resources.评估不同药物信息资源中与药物相互作用相关信息的一致性。
Cureus. 2021 Mar 8;13(3):e13766. doi: 10.7759/cureus.13766.
6
Tertiary drug information sources for treatment and prevention of COVID-19.COVID-19 的治疗和预防的三级药物信息来源。
J Med Libr Assoc. 2023 Oct 2;111(4):783-791. doi: 10.5195/jmla.2023.1662.
7
Evaluation of Point-of-Care Resources for Dietary Supplement Information.用于膳食补充剂信息的即时护理资源评估。
J Evid Based Integr Med. 2018 Jan-Dec;23:2515690X18764844. doi: 10.1177/2515690X18764844.
8
Evaluation of frequently used drug interaction screening programs.常用药物相互作用筛查程序的评估。
Pharm World Sci. 2008 Aug;30(4):367-74. doi: 10.1007/s11096-008-9191-x. Epub 2008 Apr 16.
9
Clinical decision support tools: analysis of online drug information databases.临床决策支持工具:在线药物信息数据库分析
BMC Med Inform Decis Mak. 2007 Mar 8;7:7. doi: 10.1186/1472-6947-7-7.
10
An evaluation of pharmacogenomic information provided by five common drug information resources.五种常见药物信息资源提供的药物基因组学信息评估。
J Med Libr Assoc. 2014 Jan;102(1):47-51. doi: 10.3163/1536-5050.102.1.009.

引用本文的文献

1
Tertiary drug information sources for treatment and prevention of COVID-19.COVID-19 的治疗和预防的三级药物信息来源。
J Med Libr Assoc. 2023 Oct 2;111(4):783-791. doi: 10.5195/jmla.2023.1662.
2
Off-label use information in electronic drug information resources.电子药物信息资源中的标签外使用信息。
J Med Libr Assoc. 2022 Oct 1;110(4):471-477. doi: 10.5195/jmla.2022.1419.
3
Drug interaction alerts in older primary care patients, and related medically justified actions.老年初级保健患者中的药物相互作用警报及相关有医学依据的处理措施。
Eur J Clin Pharmacol. 2022 Jul;78(7):1115-1126. doi: 10.1007/s00228-022-03292-4. Epub 2022 Mar 30.
4
Potential Psychotropic and COVID-19 Drug Interactions: A Comparison of Integrated Evidence From Six Database Programs.潜在的精神药物与新冠病毒治疗药物相互作用:六个数据库程序综合证据的比较
Cureus. 2021 Dec 10;13(12):e20319. doi: 10.7759/cureus.20319. eCollection 2021 Dec.

本文引用的文献

1
Identification and Assessment of Potential Drug-Drug Interactions in Intensive Care Unit Patients.重症监护病房患者潜在药物相互作用的识别与评估
Indian J Crit Care Med. 2019 Apr;23(4):170-174. doi: 10.5005/jp-journals-10071-23147.
2
A comparison of potential psychiatric drug interactions from six drug interaction database programs.六种药物相互作用数据库程序中潜在精神药物相互作用的比较。
Psychiatry Res. 2019 May;275:366-372. doi: 10.1016/j.psychres.2019.03.041. Epub 2019 Mar 25.
3
Identifying Common Methods Used by Drug Interaction Experts for Finding Evidence About Potential Drug-Drug Interactions: Web-Based Survey.识别药物相互作用专家用于寻找潜在药物-药物相互作用证据的常用方法:基于网络的调查。
J Med Internet Res. 2019 Jan 4;21(1):e11182. doi: 10.2196/11182.
4
Evaluation of drug information resources for drug-ethanol and drug-tobacco interactions.药物-乙醇和药物-烟草相互作用的药物信息资源评估
J Med Libr Assoc. 2019 Jan;107(1):62-71. doi: 10.5195/jmla.2019.549. Epub 2019 Jan 1.
5
Drug Interactions With New Synthetic Opioids.新型合成阿片类药物的药物相互作用
Front Pharmacol. 2018 Oct 11;9:1145. doi: 10.3389/fphar.2018.01145. eCollection 2018.
6
Neuropsychiatric and General Interactions of Natural and Synthetic Cannabinoids with Drugs of Abuse and Medicines.天然和合成大麻素与滥用药物及药品的神经精神及一般相互作用
CNS Neurol Disord Drug Targets. 2017;16(5):554-566. doi: 10.2174/1871527316666170413104516.
7
Evaluation of resources for analyzing drug interactions.分析药物相互作用的资源评估。
J Med Libr Assoc. 2016 Oct;104(4):290-295. doi: 10.3163/1536-5050.104.4.007.
8
Evaluating drug-drug interaction information in NDF-RT and DrugBank.评估NDF-RT和药物银行中的药物相互作用信息。
J Biomed Semantics. 2015 May 11;6:19. doi: 10.1186/s13326-015-0018-0. eCollection 2015.
9
Drug-drug interaction software in clinical practice: a systematic review.临床实践中的药物相互作用软件:一项系统评价
Eur J Clin Pharmacol. 2015 Feb;71(2):131-42. doi: 10.1007/s00228-014-1786-7. Epub 2014 Dec 23.
10
Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions.严重药物相互作用的识别:预防药物相互作用合作项目的结果
J Am Pharm Assoc (2003). 2004 Mar-Apr;44(2):142-51. doi: 10.1331/154434504773062591.